CAMPBELL, CA, Imperative Care, a medical technology company focused on advancing treatments for patients suffering from thromboembolic disease, has closed an oversubscribed $100 million convertible note financing.
Continue Reading
Sign up for FREE to read the full article and access 128K+ alternative investment headlines.